Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 7, 1997, Pages 1285-1293

  Ehrenreich, Hannelore ^a   Schuck, Jörg ^c   Stender, Nike ^c   Pilz, Jürgen ^c   Gefeller, Olaf ^a   Schilling, Lothar ^b   Poser, Wolfgang ^c   Kaw, Semiko ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Georg August University ^*

Author keywords

Alcoholics; Catecholamines; CRF; Mean arterial pressure; Stress

Indexed keywords

ADRENALIN; ALCOHOL; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; NORADRENALIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; AUTONOMIC DYSFUNCTION; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; STRESS;

EID: 0030815714     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04450.x     Document Type: Article

References (37)

1. Axelrod J, Reisine TD: Stress hormones: their interaction and regulation. Science 224:452-459, 1984
2. Owens MJ, Nemeroff CB: Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473, 1991
3. Fisher LA: Corticotrophin-releasing factor: endocrine and autonomic integration of responses to stress. Trends Pharmacol Sci 10:189-193,1989
4. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB: Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:167-172, 1996
5. Marks V, Wright JW: Endocrinological and metabolic effects of alcohol. Proc R Soc Med 70:337-344, 1977
6. Holsboer F, Spengler D, Heuser I: The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385-417, 1992
7. von Bardeleben U, Heuser I, Holsboer F: Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology 14:441-449, 1989
8. Adinoff B, Martin PR, Bone GHA, Eckardt MJ, Roehrich L, George DT, Boss HB, Eskay R, Linnoila M, Gold PW: Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin-releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch Gen Psychiatry 47:325-330, 1990
9. Eisenhofer G, Lambie DC, Johnson RH: Effects of ethanol on plasma catecholamines and norepinephrine clearance. Clin Pharmacol Ther 34:143-147, 1983
10. Eisenhofer G, Whiteside EA, Johnson RH: Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol. Clin Sci 68:71-78, 1985
11. Brown CG: The alcohol withdrawal syndrome. Ann Emerg Med 11:276-280, 1982
12. Black PH: Central nervous system-immune system interactions: Psychoneuroendocrinology of stress and its immune consequences. Antimicrob Agents Chemother 38:1-6, 1994
13. Smedes F, Kraak JC Poppe H: Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr Biomed Appl 231:25-39, 1982
14. O'Brien PC: Procedures for comparing samples with multiple end-points. Biometrics 40:1079-1087, 1984
15. Bregenzer T, Lehrmacher W, Gefellcr O: SAS macros for multivariate two-sample tests in the case of incomplete data, in SEUGI/Club SAS'94. Proceedings of the 12th SAS European Users Group International Conference Strasbourg, Heidelberg SAS Institute Publications, 1994, pp 760-769
16. Antoni FA: Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinology 14:76-122, 1993
17. Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Ando N, Ohtami H, Masuda T, Sasano N: Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57:34-39, 1993
18. Gaillard RC, Al-Damluji S: Stress and the pituitary adrenal axis. Ballièfre's Clin Endocrinol Metab 1:319-354, 1987
19. Trabert W, Caspari D, Bernhard P, Buro G: Inappropriate vasopressin secretion in severe alcohol withdrawal. Acta Psychiatr Scand 85: 376-379, 1992
20. Carmona-Calero E, del-Mar-Perez-Delgado M, Banuclos-Pineda J, Marrero-Gordilo N, Ferres-Torres R, Casteneyra-Pedromo A: Effects of chronic alcohol intake on the vasopressin content in the hypothalamic, paraventricular and supraoptic nuclei of the mouse. An immunohistochemical and morphometric study. Drug Alcohol Depend 38:19-24, 1995
21. Ehrenreich H, tom Dieck K, Gefeller O, Kaw S, Schilling L, Poser W, Rüther E: Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty. Psychoneuroendocrinology 22:13-24, 1997
22. Dimsdale DE, Ziegler MG: What do plasma and urinary measures of catccholamines tell us about human responses to Stressors. Circulation 83(Suppl II):II36-II42, 1991
23. Lefkowitz RJ, Huffman BB, Taylor P: Neurohumoral transmission: the autonomic and somatic motor nervous systems, in Gilman AG, Rall TW, Nies AS, Taylor P, (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. New York, Pergamon Press, 1990, pp 84-121
24. Anokhina IP, Kogan BM, Drozdov AZ: Disturbances in regulation of catecholamine neuromediation in alcoholism. Alcohol Alcohol 23:343-350, 1988
25. Hermus ARMM, Pieters GFFM Willemsen JJ, Ross HA, Smals AGH, Benraad TJ, Kloppenborg PW: Hypotensive effects of ovine and human corticotrophin-releasing factors in man. Eur J Clin Pharmacol 31:531-534, 1987
26. MacCannell KL, Lederis K, Hamilton PL, Rivier, J: Amunine (ovine CRF), urotensin 1 and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation. Pharmacology 25:116-120, 1982
27. Clifton VL, Read MA, Leitch IM, Giles WB, Boura ALA, Robinson PJ, Smith R: Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′, 5′ monophosphate-mediated pathway. J Clin Endocrinol Metab 80:2888-2893, 1995
28. Durante W, Cheng K, Sunahara RK. Schafer AI: Ethanol potentiates interleukin-1b stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells. Biochem J 308:231-236, 1995
29. Wang JF, Greenberg SS, Spritzer JJ: Chronic alcohol administration stimulates nitric oxide formation in the rat liver with or without pretreatment by lipopolysaccharide. Alcohol Clin Exp Res 19:387-393, 1995
30. Chen R, Lewis KA, Perrin MH, Vale WW: Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971, 1993
31. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le-Fur G, Caput D, Ferrara P: Primary structure and functional expression of mouse pituitary and human brain corticotropin releasing factor receptors. FEBS Lett 335:1-5, 1993
32. Perrin MH, Donaldson CJ, Chen R, Lewis, KA, Vale WW: Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133:3058-3061, 1993
33. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T: Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840, 1995
34. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W: Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973, 1995
35. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore, MP: Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9:637-645, 1995
36. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale, W: Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 91:8777-8781, 1994
37. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W: Urocortin, a mammalian neuropeptide related to fish urotertsin I and to corticotropin-releasing factor. Nature 378:287-292, 1995